{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:02:19Z","timestamp":1769090539703,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013227","name":"Ministry of Health and Welfare, Taiwan | Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["NSC 107-2314-B-002-189"],"award-info":[{"award-number":["NSC 107-2314-B-002-189"]}],"id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006732","name":"NTU | Yen Tjing Ling Industrial Research Institute, National Taiwan University","doi-asserted-by":"publisher","award":["107-N4040"],"award-info":[{"award-number":["107-N4040"]}],"id":[{"id":"10.13039\/501100006732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fragile X syndrome (FXS) is the most frequent genetic cause of intellectual disability (ID). It was previously believed that the FXS prevalence was low in Chinese population, and the cost-efficiency of FXS carrier screening was questioned. This retrospective observational study was conducted between September 2014 and May 2017 to determine the prevalence of FXS carriers in a large Chinese cohort of pregnant women. The FMR1 CGG repeat status was determined in 20,188 pregnant Taiwanese women and we identified 26 women with premutation (PM). The PM allele was transmitted to the fetus in 17 pregnancies (56.6%), and six of 17 expanded to full mutation (FM). One asymptomatic woman had a FM allele with 280 CGG repeats. Prenatal genetic diagnosis of her first fetus revealed a male carrying a <jats:italic>FMR1<\/jats:italic> gene deletion of 5\u2032 UTR and exon 1. Her second fetus was a female carrying a FM allele as well. This is so far the largest study of the FXS carrier screening in Chinese women. The prevalence of premutation allele for FXS in normal asymptomatic Taiwanese women was found to be as high as 0.13% (1 in 777) in this study. The empirical evidence suggests that reproductive FXS carrier screening in Taiwan might be cost-effective.<\/jats:p>","DOI":"10.1038\/s41598-019-51726-4","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:29:48Z","timestamp":1572467388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fragile X syndrome carrier screening in pregnant women in Chinese Han population"],"prefix":"10.1038","volume":"9","author":[{"given":"Chia-Cheng","family":"Hung","sequence":"first","affiliation":[]},{"given":"Chien-Nan","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Yu-Chu","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Chih-Ling","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Tze-Kang","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Yi-Ning","family":"Su","sequence":"additional","affiliation":[]},{"given":"Ming-Wei","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Jessica","family":"Kang","sequence":"additional","affiliation":[]},{"given":"Yi-Yun","family":"Tai","sequence":"additional","affiliation":[]},{"given":"Wen-Wei","family":"Hsu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0753-2793","authenticated-orcid":false,"given":"Shin-Yu","family":"Lin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"51726_CR1","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1126\/science.1675488","volume":"252","author":"EJ Kremer","year":"1991","unstructured":"Kremer, E. J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711\u20131714 (1991).","journal-title":"Science"},{"key":"51726_CR2","doi-asserted-by":"crossref","unstructured":"Maddalena, A. et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 3, 200\u2013205, doi:10.109700125817-200105000-00010 (2001).","DOI":"10.1097\/00125817-200105000-00010"},{"key":"51726_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/367713","volume":"72","author":"SL Nolin","year":"2003","unstructured":"Nolin, S. L. et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72, 454\u2013464 (2003).","journal-title":"Am J Hum Genet"},{"key":"51726_CR4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/jmg.2006.042374","volume":"43","author":"S Jacquemont","year":"2006","unstructured":"Jacquemont, S., Leehey, M. A., Hagerman, R. J., Beckett, L. A. & Hagerman, P. J. Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet 43, 804\u2013809, https:\/\/doi.org\/10.1136\/jmg.2006.042374 (2006).","journal-title":"J Med Genet"},{"key":"51726_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.0.CO;2-5","volume":"84","author":"ML Uzielli","year":"1999","unstructured":"Uzielli, M. L. et al. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 84, 300\u2013303 (1999).","journal-title":"Am J Med Genet"},{"key":"51726_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajmg.a.30528","volume":"133A","author":"CC Tzeng","year":"2005","unstructured":"Tzeng, C. C. et al. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am J Med Genet A 133A, 37\u201343, https:\/\/doi.org\/10.1002\/ajmg.a.30528 (2005).","journal-title":"Am J Med Genet A"},{"key":"51726_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.12809\/hkmj164936","volume":"23","author":"YK Cheng","year":"2017","unstructured":"Cheng, Y. K. et al. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis. Hong Kong Med J 23, 110\u2013116, https:\/\/doi.org\/10.12809\/hkmj164936 (2017).","journal-title":"Hong Kong Med J"},{"key":"51726_CR8","first-page":"204","volume":"66","author":"KF Huang","year":"2003","unstructured":"Huang, K. F. et al. Original article pilot screening for fragile X carrier in pregnant women of southern Taiwan. J Chin Med Assoc 66, 204\u2013209 (2003).","journal-title":"J Chin Med Assoc"},{"key":"51726_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1034\/j.1399-0004.1999.550509.x","volume":"55","author":"SC Chiang","year":"1999","unstructured":"Chiang, S. C., Lee, Y. M., Wang, T. R. & Hwu, W. L. Allele distribution at the FMR1 locus in the general Chinese population. Clin Genet 55, 352\u2013355 (1999).","journal-title":"Clin Genet"},{"key":"51726_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/cge.12195","volume":"85","author":"JH Jang","year":"2014","unstructured":"Jang, J. H. et al. Frequency of FMR1 premutation carriers and rate of expansion to full mutation in a retrospective diagnostic FMR1 Korean sample. Clin Genet 85, 441\u2013445, https:\/\/doi.org\/10.1111\/cge.12195 (2014).","journal-title":"Clin Genet"},{"key":"51726_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/0969141313488364","volume":"20","author":"MJ Kim","year":"2013","unstructured":"Kim, M. J. et al. Fragile X carrier screening in Korean women of reproductive age. J Med Screen 20, 15\u201320, https:\/\/doi.org\/10.1177\/0969141313488364 (2013).","journal-title":"J Med Screen"},{"key":"51726_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/gim.2013.47","volume":"15","author":"WW Grody","year":"2013","unstructured":"Grody, W. W. et al. ACMG position statement on prenatal\/preconception expanded carrier screening. Genet Med 15, 482\u2013483, https:\/\/doi.org\/10.1038\/gim.2013.47 (2013).","journal-title":"Genet Med"},{"key":"51726_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/mgg3.128","volume":"3","author":"W Huang","year":"2015","unstructured":"Huang, W. et al. Distribution of fragile X mental retardation 1 CGG repeat and flanking haplotypes in a large Chinese population. Mol Genet Genomic Med 3, 172\u2013181, https:\/\/doi.org\/10.1002\/mgg3.128 (2015).","journal-title":"Mol Genet Genomic Med"},{"key":"51726_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/sj.ejhg.5200285","volume":"7","author":"M Ryynanen","year":"1999","unstructured":"Ryynanen, M. et al. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 7, 212\u2013216, https:\/\/doi.org\/10.1038\/sj.ejhg.5200285 (1999).","journal-title":"Eur J Hum Genet"},{"key":"51726_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1086\/321974","volume":"69","author":"H Toledano-Alhadef","year":"2001","unstructured":"Toledano-Alhadef, H. et al. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet 69, 351\u2013360, https:\/\/doi.org\/10.1086\/321974 (2001).","journal-title":"Am J Hum Genet"},{"key":"51726_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/AOG.0b013e318163be0b","volume":"111","author":"A Cronister","year":"2008","unstructured":"Cronister, A., Teicher, J., Rohlfs, E. M., Donnenfeld, A. & Hallam, S. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Obstet Gynecol 111, 596\u2013601, https:\/\/doi.org\/10.1097\/AOG.0b013e318163be0b (2008).","journal-title":"Obstet Gynecol"},{"key":"51726_CR17","first-page":"1006","volume":"57","author":"F Rousseau","year":"1995","unstructured":"Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W. & Morgan, K. Prevalence of carriers of premutation-size alleles of the FMRI gene\u2013and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57, 1006\u20131018 (1995).","journal-title":"Am J Hum Genet"},{"key":"51726_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/gim.2018.52","volume":"20","author":"CM Kraan","year":"2018","unstructured":"Kraan, C. M. et al. FMR1 allele size distribution in 35,000 males and females: a comparison of developmental delay and general population cohorts. Genet Med 20, 1627\u20131634, https:\/\/doi.org\/10.1038\/gim.2018.52 (2018).","journal-title":"Genet Med"},{"key":"51726_CR19","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","volume":"129","author":"G Committee on","year":"2017","unstructured":"Committee on, G. Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol 129, e41\u2013e55, https:\/\/doi.org\/10.1097\/AOG.0000000000001952 (2017).","journal-title":"Obstet Gynecol"},{"key":"51726_CR20","unstructured":"Screening, H. R. J. C. o. P. D. a. Prenatal screening and diagnostic testing for fetal chromosomal and genetic conditions. (2018)."},{"key":"51726_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/(SICI)1096-8628(19971112)72:4<430::AID-AJMG11>3.0.CO;2-S","volume":"72","author":"LS Hammond","year":"1997","unstructured":"Hammond, L. S., Macias, M. M., Tarleton, J. C. & Shashidhar Pai, G. Fragile X syndrome and deletions in FMR1: new case and review of the literature. Am J Med Genet 72, 430\u2013434 (1997).","journal-title":"Am J Med Genet"},{"key":"51726_CR22","unstructured":"Saul, R. A. & Tarleton, J. C. In GeneReviews(R) (eds Adam, M. P. et al.) (1993)."},{"key":"51726_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.mcp.2014.08.003","volume":"28","author":"M Handt","year":"2014","unstructured":"Handt, M. et al. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening. Mol Cell Probes 28, 279\u2013283, https:\/\/doi.org\/10.1016\/j.mcp.2014.08.003 (2014).","journal-title":"Mol Cell Probes"},{"key":"51726_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4137\/JEN.S25524","volume":"9","author":"JA Suhl","year":"2015","unstructured":"Suhl, J. A. & Warren, S. T. Single-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRP. J Exp Neurosci 9, 35\u201341, https:\/\/doi.org\/10.4137\/JEN.S25524 (2015).","journal-title":"J Exp Neurosci"},{"key":"51726_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40348-014-0001-3","volume":"1","author":"CJ Westmark","year":"2014","unstructured":"Westmark, C. J. The quest for fragile X biomarkers. Mol Cell Pediatr 1, 1, https:\/\/doi.org\/10.1186\/s40348-014-0001-3 (2014).","journal-title":"Mol Cell Pediatr"},{"key":"51726_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12013-016-0722-0","volume":"74","author":"A Tekcan","year":"2016","unstructured":"Tekcan, A. In Silico Analysis of FMR1 Gene Missense SNPs. Cell Biochem Biophys 74, 109\u2013127, https:\/\/doi.org\/10.1007\/s12013-016-0722-0 (2016).","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"51726_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.ajog.2005.02.052","volume":"192","author":"Thomas J. Musci","year":"2005","unstructured":"Musci, T. J. & Caughey, A. B. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening. Am J Obstet Gynecol 192, 1905\u20131912, discussion 1912\u20131905, https:\/\/doi.org\/10.1016\/j.ajog.2005.02.052 (2005).","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"51726_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7160","volume":"7","author":"FJ Song","year":"2003","unstructured":"Song, F. J., Barton, P., Sleightholme, V., Yao, G. L. & Fry-Smith, A. Screening for fragile X syndrome: a literature review and modelling study. Health Technol Assess 7, 1\u2013106 (2003).","journal-title":"Health Technol Assess"},{"key":"51726_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.12809\/hkmj175064","volume":"23","author":"AS Mak","year":"2017","unstructured":"Mak, A. S. & Leung, K. Y. Challenges in prenatal screening and counselling for fragile X syndrome. Hong Kong Med J 23, 108\u2013109, https:\/\/doi.org\/10.12809\/hkmj175064 (2017).","journal-title":"Hong Kong Med J"},{"key":"51726_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13052-017-0355-y","volume":"43","author":"C Ciaccio","year":"2017","unstructured":"Ciaccio, C. et al. Fragile X syndrome: a review of clinical and molecular diagnoses. Ital J Pediatr 43, 39, https:\/\/doi.org\/10.1186\/s13052-017-0355-y (2017).","journal-title":"Ital J Pediatr"},{"key":"51726_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.291.4.460","volume":"291","author":"S Jacquemont","year":"2004","unstructured":"Jacquemont, S. et al. Penetrance of the fragile X-associated tremor\/ataxia syndrome in a premutation carrier population. JAMA 291, 460\u2013469, https:\/\/doi.org\/10.1001\/jama.291.4.460 (2004).","journal-title":"JAMA"},{"key":"51726_CR32","doi-asserted-by":"crossref","unstructured":"Sherman, S. L. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97, 189\u2013194, doi:10.1002\/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J (2000).","DOI":"10.1002\/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J"},{"key":"51726_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/gim.2012.34","volume":"14","author":"CM Yrigollen","year":"2012","unstructured":"Yrigollen, C. M. et al. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med 14, 729\u2013736, https:\/\/doi.org\/10.1038\/gim.2012.34 (2012).","journal-title":"Genet Med"},{"key":"51726_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/gim.2013.61","volume":"15","author":"KG Monaghan","year":"2013","unstructured":"Monaghan, K. G., Lyon, E. & Spector, E. B. Erican College of Medical, G. & Genomics. ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics. Genet Med 15, 575\u2013586, https:\/\/doi.org\/10.1038\/gim.2013.61 (2013).","journal-title":"Genet Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51726-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51726-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51726-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:01:16Z","timestamp":1671289276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51726-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51726"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51726-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15456"}}